CLINICAL_TRIALS
trial_result
· 2016-04-27
Clinical Trial Update: The Evaluation of Belimumab in Myasthenia Gravis (MG) [Phase 2]
Summary
Phase 2 clinical trial evaluating belimumab for myasthenia gravis has completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Myasthaenia Gravis | Phase 2 | Status: COMPLETED | Results posted: 2016-04-27